In the last 12 months, insiders at Immunovant, Inc. ($IMVT) filed 195 transactions with the SEC: 1 open-market purchases totaling $349,999,986 and 132 sales totaling $14,200,601. Net insider sentiment: net buying.
Immunovant, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Roivant Sciences Ltd. (Not found) — 1 transaction totaling $349,999,986
- Venker Eric (Chief Executive Officer) — 8 transactions totaling $14,082,475
- Salzmann Peter (Chief Executive Officer) — 24 transactions totaling $5,082,186
- Barnett Eva Renee (Chief Financial Officer) — 26 transactions totaling $1,943,489
- Levine Mark S. (Chief Legal Officer) — 17 transactions totaling $1,282,959
View all SEC Filings for Immunovant, Inc. (IMVT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Venker Eric | Chief Executive Officer | D | Common Stock | 334960 | $25.10 | 33,790.0000 | 203,532,180 | 90.84% | 0.16% |
| April 1, 2026 | Venker Eric | Chief Executive Officer | M | Common Stock | 368750 | $14.46 | 368,750.0000 | 203,532,180 | 9999.99% | 0.18% |
| April 2, 2026 | Venker Eric | Chief Executive Officer | S | Common Stock | 1409 | $24.60 | 19,561.0000 | 203,532,180 | 6.72% | 0.00% |
| April 1, 2026 | Venker Eric | Chief Executive Officer | M | Capped Value Appreciation Rights | 368750 | $0.00 | 1,106,250.0000 | 203,532,180 | 25.00% | 0.18% |
| April 2, 2026 | Venker Eric | Chief Executive Officer | S | Common Stock | 12820 | $24.04 | 20,970.0000 | 203,532,180 | 37.94% | 0.01% |
| March 18, 2026 | Van Tuyl Christopher | Chief Legal Officer | S | Common Stock | 2877 | $24.97 | 147,053.0000 | 203,532,180 | 1.92% | 0.00% |
| Feb. 25, 2026 | Gloria Melanie | Chief Operating Officer | S | Common Stock | 942 | $28.90 | 170,273.0000 | 203,532,180 | 0.55% | 0.00% |
| Feb. 25, 2026 | Gloria Melanie | Chief Operating Officer | S | Common Stock | 859 | $28.16 | 171,215.0000 | 203,532,180 | 0.50% | 0.00% |
| Feb. 25, 2026 | Gloria Melanie | Chief Operating Officer | S | Common Stock | 1437 | $26.98 | 172,074.0000 | 203,532,180 | 0.83% | 0.00% |
| Jan. 21, 2026 | Stout Jay S | Chief Technology Officer | S | Common Stock | 1977 | $26.03 | 197,634.0000 | 175,276,526 | 0.99% | 0.00% |
| Jan. 7, 2026 | Stout Jay S | Chief Technology Officer | S | Common Stock | 1148 | $26.51 | 199,666.0000 | 175,276,526 | 0.57% | 0.00% |
| Jan. 7, 2026 | Stout Jay S | Chief Technology Officer | S | Common Stock | 55 | $26.92 | 199,611.0000 | 175,276,526 | 0.03% | 0.00% |
| Dec. 18, 2025 | Van Tuyl Christopher | Chief Legal Officer | S | Common Stock | 8529 | $26.78 | 152,214.0000 | 175,276,526 | 5.31% | 0.00% |
| Dec. 18, 2025 | Van Tuyl Christopher | Chief Legal Officer | S | Common Stock | 2284 | $27.38 | 149,930.0000 | 175,276,526 | 1.50% | 0.00% |
| Dec. 12, 2025 | Roivant Sciences Ltd. | Not found | P | Common Stock, $0.0001 par value per share | 16666666 | $21.00 | 113,317,007.0000 | 175,276,526 | 17.24% | 9.51% |
| Dec. 1, 2025 | Fromkin Andrew J. | Director | S | Common Stock | 19351 | $23.14 | 88,750.0000 | 175,276,526 | 17.90% | 0.01% |
| Dec. 1, 2025 | Hughes Douglas J. | Director | S | Common Stock | 13091 | $23.14 | 122,682.0000 | 175,276,526 | 9.64% | 0.01% |
| Dec. 1, 2025 | Hughes Douglas J. | Director | S | Common Stock | 1909 | $23.96 | 120,773.0000 | 175,276,526 | 1.56% | 0.00% |
| Dec. 1, 2025 | Fromkin Andrew J. | Director | S | Common Stock | 2898 | $23.95 | 85,852.0000 | 175,276,526 | 3.27% | 0.00% |
| Nov. 20, 2025 | Gloria Melanie | Chief Operating Officer | S | Common Stock | 2375 | $23.97 | 173,511.0000 | 175,276,526 | 1.35% | 0.00% |
| Nov. 20, 2025 | Gloria Melanie | Chief Operating Officer | S | Common Stock | 10251 | $23.54 | 175,886.0000 | 175,276,526 | 5.51% | 0.01% |
| Oct. 22, 2025 | Stout Jay S | Chief Technology Officer | S | Common Stock | 2520 | $19.03 | 200,814.0000 | 170,923,191 | 1.24% | 0.00% |
| Oct. 22, 2025 | Geffner Michael | Chief Medical Officer | S | Common Stock | 2595 | $19.03 | 217,958.0000 | 170,923,191 | 1.18% | 0.00% |
| Oct. 8, 2025 | Stout Jay S | Chief Technology Officer | S | Common Stock | 1585 | $16.30 | 203,334.0000 | 170,923,191 | 0.77% | 0.00% |
| Oct. 8, 2025 | Geffner Michael | Chief Medical Officer | S | Common Stock | 1272 | $16.30 | 220,553.0000 | 170,923,191 | 0.57% | 0.00% |
| July 28, 2025 | Venker Eric | Chief Executive Officer | A | Capped Value Appreciation Rights | 1475000 | $0.00 | 1,475,000.0000 | 170,923,191 | 9999.99% | 0.86% |
| July 28, 2025 | Venker Eric | Chief Executive Officer | A | Stock Option (right to buy) | 189900 | $0.00 | 189,900.0000 | 170,923,191 | 9999.99% | 0.11% |
| July 28, 2025 | Venker Eric | Chief Executive Officer | A | Stock Option (right to buy) | 1300000 | $0.00 | 1,300,000.0000 | 170,923,191 | 9999.99% | 0.76% |
| July 23, 2025 | Geffner Michael | Chief Medical Officer | S | Common Stock | 2385 | $18.15 | 221,825.0000 | 170,923,191 | 1.06% | 0.00% |
| July 23, 2025 | Stout Jay S | Chief Technology Officer | S | Common Stock | 2805 | $18.15 | 204,919.0000 | 170,923,191 | 1.35% | 0.00% |
| July 9, 2025 | Stout Jay S | Chief Technology Officer | S | Common Stock | 1519 | $17.24 | 207,724.0000 | 170,923,191 | 0.73% | 0.00% |
| July 9, 2025 | Geffner Michael | Chief Medical Officer | S | Common Stock | 1160 | $17.24 | 224,210.0000 | 170,923,191 | 0.51% | 0.00% |
| May 1, 2025 | Bauer Jake | Not found | A | Stock Option (Right to Buy) | 35234 | $0.00 | 35,234.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2025 | Susman Robert Graham | Not found | A | Common Stock | 25016 | $0.00 | 25,016.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2025 | Susman Robert Graham | Not found | A | Stock Option (Right to Buy) | 35234 | $0.00 | 35,234.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2025 | Girao Tiago | Chief Financial Officer | A | Common Stock | 208388 | $0.00 | 208,388.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2025 | Girao Tiago | Chief Financial Officer | A | Stock Option (Right to Buy) | 293505 | $0.00 | 293,505.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2025 | Bauer Jake | Not found | A | Common Stock | 25016 | $0.00 | 25,016.0000 | 0 | 9999.99% | 0.00% |
| April 23, 2025 | Stout Jay S | Chief Technology Officer | S | Common Stock | 1925 | $14.79 | 209,243.0000 | 0 | 0.91% | 0.00% |
| April 23, 2025 | Geffner Michael | Chief Medical Officer | S | Common Stock | 2349 | $14.79 | 225,370.0000 | 0 | 1.03% | 0.00% |
| April 16, 2025 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 8321 | $14.89 | 1,178,191.0000 | 0 | 0.70% | 0.00% |
| April 16, 2025 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2993 | $14.89 | 396,774.0000 | 0 | 0.75% | 0.00% |
| April 9, 2025 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 4050 | $12.99 | 399,767.0000 | 0 | 1.00% | 0.00% |
| April 9, 2025 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 28094 | $12.99 | 1,186,512.0000 | 0 | 2.31% | 0.00% |
| April 9, 2025 | Geffner Michael | Chief Medical Officer | S | Common Stock | 6169 | $12.99 | 227,719.0000 | 0 | 2.64% | 0.00% |
| April 9, 2025 | Stout Jay S | Chief Technology Officer | S | Common Stock | 5004 | $12.99 | 211,168.0000 | 0 | 2.31% | 0.00% |
| April 9, 2025 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 7013 | $12.99 | 403,817.0000 | 0 | 1.71% | 0.00% |
| April 1, 2025 | Gloria Melanie | Chief Operating Officer | A | Common Stock | 76181 | $0.00 | 186,137.0000 | 0 | 69.28% | 0.00% |
| April 1, 2025 | Van Tuyl Christopher | Chief Legal Officer | A | Common Stock | 50787 | $0.00 | 160,743.0000 | 0 | 46.19% | 0.00% |
| April 1, 2025 | Van Tuyl Christopher | Chief Legal Officer | A | Stock Option (right to buy) | 71531 | $0.00 | 71,531.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2025 | Gloria Melanie | Chief Operating Officer | A | Stock Option (right to buy) | 107297 | $0.00 | 107,297.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2025 | Stout Jay S | Chief Technology Officer | A | Common Stock | 76181 | $0.00 | 216,172.0000 | 0 | 54.42% | 0.00% |
| April 1, 2025 | Stout Jay S | Chief Technology Officer | A | Stock Option (right to buy) | 107297 | $0.00 | 107,297.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2025 | Geffner Michael | Chief Medical Officer | A | Common Stock | 101574 | $0.00 | 233,888.0000 | 0 | 76.77% | 0.00% |
| April 1, 2025 | Geffner Michael | Chief Medical Officer | A | Stock Option (right to buy) | 143063 | $0.00 | 143,063.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2025 | Barnett Eva Renee | Chief Financial Officer | A | Common Stock | 88878 | $0.00 | 410,830.0000 | 0 | 27.61% | 0.00% |
| April 1, 2025 | Barnett Eva Renee | Chief Financial Officer | A | Stock Option (right to buy) | 125180 | $0.00 | 125,180.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2025 | Salzmann Peter | Chief Executive Officer | A | Common Stock | 265820 | $0.00 | 1,214,606.0000 | 0 | 28.02% | 0.00% |
| April 1, 2025 | Salzmann Peter | Chief Executive Officer | A | Stock Option (right to buy) | 374395 | $0.00 | 374,395.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2025 | Pande Atul | Director | A | Common Stock | 16188 | $0.00 | 122,851.0000 | 0 | 15.18% | 0.00% |
| April 1, 2025 | Pande Atul | Director | A | Stock Option (right to buy) | 7600 | $0.00 | 7,600.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2025 | Hughes Douglas J. | Director | A | Common Stock | 16188 | $0.00 | 135,773.0000 | 0 | 13.54% | 0.00% |
| April 1, 2025 | Hughes Douglas J. | Director | A | Stock Option (right to buy) | 7600 | $0.00 | 7,600.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2025 | Fromkin Andrew J. | Director | A | Common Stock | 16188 | $0.00 | 108,101.0000 | 0 | 17.61% | 0.00% |
| April 1, 2025 | Fromkin Andrew J. | Director | A | Stock Option (right to buy) | 7600 | $0.00 | 7,600.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2025 | MIGAUSKY GEORGE V | Director | A | Common Stock | 16188 | $0.00 | 137,251.0000 | 0 | 13.37% | 0.00% |
| April 1, 2025 | MIGAUSKY GEORGE V | Director | A | Stock Option (right to buy) | 7600 | $0.00 | 7,600.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2025 | Torti Frank | Director | A | Common Stock | 199365 | $0.00 | 835,039.0000 | 0 | 31.36% | 0.00% |
| April 1, 2025 | Torti Frank | Director | A | Stock Option (right to buy) | 93599 | $0.00 | 93,599.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2025 | Fromkin Andrew J. | Director | S | Common Stock | 1384 | $19.96 | 91,913.0000 | 0 | 1.48% | 0.00% |
| March 7, 2025 | Fromkin Andrew J. | Director | S | Common Stock | 6616 | $19.52 | 93,297.0000 | 0 | 6.62% | 0.00% |
| Feb. 19, 2025 | Macias William L. | Chief Medical Officer | S | Common Stock | 2055 | $20.86 | 357,353.0000 | 0 | 0.57% | 0.00% |
| Feb. 19, 2025 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 15439 | $20.86 | 948,786.0000 | 0 | 1.60% | 0.00% |
| Feb. 19, 2025 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2814 | $20.86 | 321,952.0000 | 0 | 0.87% | 0.00% |
| Jan. 22, 2025 | Stout Jay S | Chief Technology Officer | S | Common Stock | 2195 | $23.59 | 139,991.0000 | 0 | 1.54% | 0.00% |
| Jan. 22, 2025 | Geffner Michael | Chief Medical Officer | S | Common Stock | 2657 | $23.59 | 132,314.0000 | 0 | 1.97% | 0.00% |
| Jan. 15, 2025 | Macias William L. | Chief Medical Officer | S | Common Stock | 387 | $23.81 | 359,427.0000 | 0 | 0.11% | 0.00% |
| Jan. 15, 2025 | Macias William L. | Chief Medical Officer | S | Common Stock | 94 | $24.19 | 359,814.0000 | 0 | 0.03% | 0.00% |
| Jan. 15, 2025 | Macias William L. | Chief Medical Officer | S | Common Stock | 1883 | $23.81 | 359,908.0000 | 0 | 0.52% | 0.00% |
| Jan. 15, 2025 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 415 | $24.19 | 964,225.0000 | 0 | 0.04% | 0.00% |
| Jan. 15, 2025 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 8352 | $23.81 | 964,640.0000 | 0 | 0.86% | 0.00% |
| Jan. 15, 2025 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2189 | $23.81 | 324,875.0000 | 0 | 0.67% | 0.00% |
| Jan. 15, 2025 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 109 | $24.19 | 324,766.0000 | 0 | 0.03% | 0.00% |
| Jan. 15, 2025 | Macias William L. | Chief Medical Officer | S | Common Stock | 19 | $24.19 | 359,408.0000 | 0 | 0.01% | 0.00% |
| Jan. 8, 2025 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 4105 | $24.10 | 327,064.0000 | 0 | 1.24% | 0.00% |
| Jan. 8, 2025 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 5105 | $24.10 | 972,992.0000 | 0 | 0.52% | 0.00% |
| Dec. 16, 2024 | Van Tuyl Christopher | Chief Legal Officer | A | Stock Option (right to buy) | 137446 | $0.00 | 137,446.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2024 | Van Tuyl Christopher | Chief Legal Officer | A | Common Stock | 109956 | $0.00 | 109,956.0000 | 0 | 9999.99% | 0.00% |
| Dec. 2, 2024 | Pande Atul | Director | S | Common Stock | 7750 | $28.54 | 106,663.0000 | 0 | 6.77% | 0.00% |
| Dec. 2, 2024 | Hughes Douglas J. | Director | S | Common Stock | 5425 | $28.54 | 119,585.0000 | 0 | 4.34% | 0.00% |
| Nov. 20, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 4174 | $25.45 | 331,169.0000 | 0 | 1.24% | 0.00% |
| Nov. 20, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 3353 | $25.45 | 361,791.0000 | 0 | 0.92% | 0.00% |
| Nov. 20, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 3650 | $25.45 | 319,228.0000 | 0 | 1.13% | 0.00% |
| Nov. 20, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 16692 | $25.45 | 978,097.0000 | 0 | 1.68% | 0.00% |
| Nov. 18, 2024 | Gloria Melanie | Chief Operating Officer | A | Stock Option (right to buy) | 137446 | $0.00 | 137,446.0000 | 0 | 9999.99% | 0.00% |
| Nov. 18, 2024 | Gloria Melanie | Chief Operating Officer | A | Common Stock | 109956 | $0.00 | 109,956.0000 | 0 | 9999.99% | 0.00% |
| Oct. 23, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 4361 | $29.53 | 322,878.0000 | 0 | 1.33% | 0.00% |
| Oct. 23, 2024 | Stout Jay S | Chief Technology Officer | S | Common Stock | 2740 | $29.53 | 142,186.0000 | 0 | 1.89% | 0.00% |
| Oct. 23, 2024 | Geffner Michael | Chief Medical Officer | S | Common Stock | 3189 | $29.53 | 134,971.0000 | 0 | 2.31% | 0.00% |
| Oct. 16, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 9095 | $28.79 | 994,789.0000 | 0 | 0.91% | 0.00% |
| Oct. 16, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 2627 | $28.79 | 365,705.0000 | 0 | 0.71% | 0.00% |
| Oct. 16, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 561 | $28.79 | 365,144.0000 | 0 | 0.15% | 0.00% |
| Oct. 16, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 2860 | $28.79 | 327,239.0000 | 0 | 0.87% | 0.00% |
| Oct. 16, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 3271 | $28.79 | 335,343.0000 | 0 | 0.97% | 0.00% |
| Oct. 9, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 5162 | $29.56 | 338,614.0000 | 0 | 1.50% | 0.00% |
| Oct. 9, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 4460 | $29.56 | 1,003,884.0000 | 0 | 0.44% | 0.00% |
| Aug. 21, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 120 | $32.32 | 368,332.0000 | 0 | 0.03% | 0.00% |
| Aug. 21, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 3164 | $31.84 | 330,230.0000 | 0 | 0.95% | 0.00% |
| Aug. 21, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 131 | $32.32 | 330,099.0000 | 0 | 0.04% | 0.00% |
| Aug. 21, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 2907 | $31.84 | 368,452.0000 | 0 | 0.78% | 0.00% |
| Aug. 21, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 3619 | $31.84 | 343,925.0000 | 0 | 1.04% | 0.00% |
| Aug. 21, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 149 | $32.32 | 343,776.0000 | 0 | 0.04% | 0.00% |
| Aug. 21, 2024 | Butchko Julia G. | Chief Development Officer | S | Common Stock | 2907 | $31.84 | 441,079.0000 | 0 | 0.65% | 0.00% |
| Aug. 21, 2024 | Butchko Julia G. | Chief Development Officer | S | Common Stock | 120 | $32.32 | 440,959.0000 | 0 | 0.03% | 0.00% |
| Aug. 21, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 14470 | $31.84 | 1,008,942.0000 | 0 | 1.41% | 0.00% |
| Aug. 21, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 598 | $32.32 | 1,008,344.0000 | 0 | 0.06% | 0.00% |
| July 24, 2024 | Geffner Michael | Chief Medical Officer | S | Common Stock | 3456 | $27.76 | 138,160.0000 | 0 | 2.44% | 0.00% |
| July 24, 2024 | Stout Jay S | Chief Technology Officer | S | Common Stock | 2813 | $27.76 | 144,926.0000 | 0 | 1.90% | 0.00% |
| July 24, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 4015 | $27.76 | 333,394.0000 | 0 | 1.19% | 0.00% |
| July 17, 2024 | Butchko Julia G. | Chief Development Officer | S | Common Stock | 169 | $30.55 | 443,986.0000 | 0 | 0.04% | 0.00% |
| July 17, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 510 | $30.55 | 1,023,412.0000 | 0 | 0.05% | 0.00% |
| July 17, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 2358 | $29.64 | 337,556.0000 | 0 | 0.69% | 0.00% |
| July 17, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 147 | $30.55 | 337,409.0000 | 0 | 0.04% | 0.00% |
| July 17, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 2362 | $29.64 | 372,041.0000 | 0 | 0.63% | 0.00% |
| July 17, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 147 | $30.55 | 371,894.0000 | 0 | 0.04% | 0.00% |
| July 17, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 504 | $29.64 | 371,390.0000 | 0 | 0.14% | 0.00% |
| July 17, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 31 | $30.55 | 371,359.0000 | 0 | 0.01% | 0.00% |
| July 17, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2939 | $29.64 | 347,728.0000 | 0 | 0.84% | 0.00% |
| July 17, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 184 | $30.55 | 347,544.0000 | 0 | 0.05% | 0.00% |
| July 17, 2024 | Butchko Julia G. | Chief Development Officer | S | Common Stock | 2698 | $29.64 | 444,155.0000 | 0 | 0.60% | 0.00% |
| July 17, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 8175 | $29.64 | 1,023,922.0000 | 0 | 0.79% | 0.00% |
| July 9, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 4747 | $28.06 | 350,667.0000 | 0 | 1.34% | 0.00% |
| July 9, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 4619 | $28.06 | 1,032,097.0000 | 0 | 0.45% | 0.00% |
| July 9, 2024 | Butchko Julia G. | Chief Development Officer | S | Common Stock | 1527 | $28.06 | 446,853.0000 | 0 | 0.34% | 0.00% |
| May 22, 2024 | Butchko Julia G. | Chief Development Officer | S | Common Stock | 3247 | $29.65 | 448,380.0000 | 0 | 0.72% | 0.00% |
| May 22, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 3247 | $29.65 | 374,403.0000 | 0 | 0.86% | 0.00% |
| May 22, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 3242 | $29.65 | 339,914.0000 | 0 | 0.94% | 0.00% |
| May 22, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 4042 | $29.65 | 355,414.0000 | 0 | 1.12% | 0.00% |
| May 22, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 16163 | $29.65 | 1,036,716.0000 | 0 | 1.54% | 0.00% |
| April 24, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 3963 | $28.90 | 343,156.0000 | 0 | 1.14% | 0.00% |
| April 24, 2024 | Geffner Michael | Chief Medical Officer | S | Common Stock | 3261 | $28.90 | 141,616.0000 | 0 | 2.25% | 0.00% |
| April 24, 2024 | Stout Jay S | Chief Technology Officer | S | Common Stock | 7239 | $28.90 | 147,739.0000 | 0 | 4.67% | 0.00% |
| April 17, 2024 | Butchko Julia G. | Chief Development Officer | S | Common Stock | 7825 | $28.80 | 453,917.0000 | 0 | 1.69% | 0.00% |
| April 17, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 7602 | $28.80 | 349,344.0000 | 0 | 2.13% | 0.00% |
| April 17, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 2225 | $29.94 | 347,119.0000 | 0 | 0.64% | 0.00% |
| April 17, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 6136 | $28.80 | 379,794.0000 | 0 | 1.59% | 0.00% |
| April 17, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 1796 | $29.94 | 377,998.0000 | 0 | 0.47% | 0.00% |
| April 17, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 269 | $28.80 | 377,729.0000 | 0 | 0.07% | 0.00% |
| April 17, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 79 | $29.94 | 377,650.0000 | 0 | 0.02% | 0.00% |
| April 17, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 9479 | $28.80 | 362,230.0000 | 0 | 2.55% | 0.00% |
| April 17, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2774 | $29.94 | 359,456.0000 | 0 | 0.77% | 0.00% |
| April 17, 2024 | Butchko Julia G. | Chief Development Officer | S | Common Stock | 2290 | $29.94 | 451,627.0000 | 0 | 0.50% | 0.00% |
| April 17, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 26365 | $28.80 | 1,060,593.0000 | 0 | 2.43% | 0.00% |
| April 17, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 7714 | $29.94 | 1,052,879.0000 | 0 | 0.73% | 0.00% |
| April 9, 2024 | Butchko Julia G. | Chief Development Officer | S | Common Stock | 1053 | $31.18 | 461,742.0000 | 0 | 0.23% | 0.00% |
| April 9, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 4807 | $31.18 | 1,086,958.0000 | 0 | 0.44% | 0.00% |
| April 9, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 3689 | $31.18 | 371,709.0000 | 0 | 0.98% | 0.00% |
| April 2, 2024 | Hughes Douglas J. | Director | A | Common Stock | 11255 | $0.00 | 125,010.0000 | 0 | 9.89% | 0.00% |
| April 2, 2024 | Salzmann Peter | Chief Executive Officer | A | Stock Option (right to buy) | 200667 | $0.00 | 200,667.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | Levine Mark S. | Chief Legal Officer | A | Stock Option (right to buy) | 68723 | $0.00 | 68,723.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | Levine Mark S. | Chief Legal Officer | A | Common Stock | 54978 | $0.00 | 356,946.0000 | 0 | 18.21% | 0.00% |
| April 2, 2024 | Stout Jay S | Chief Technology Officer | A | Stock Option (right to buy) | 68723 | $0.00 | 68,723.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | Stout Jay S | Chief Technology Officer | A | Common Stock | 54978 | $0.00 | 154,978.0000 | 0 | 54.98% | 0.00% |
| April 2, 2024 | Torti Frank | Director | A | Stock Option (right to buy) | 50167 | $0.00 | 50,167.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | Torti Frank | Director | A | Common Stock | 120400 | $0.00 | 635,674.0000 | 0 | 23.37% | 0.00% |
| April 2, 2024 | Pande Atul | Director | A | Stock Option (right to buy) | 4690 | $0.00 | 4,690.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | Pande Atul | Director | A | Common Stock | 11255 | $0.00 | 114,413.0000 | 0 | 10.91% | 0.00% |
| April 2, 2024 | MIGAUSKY GEORGE V | Director | A | Stock Option (right to buy) | 4690 | $0.00 | 4,690.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | MIGAUSKY GEORGE V | Director | A | Common Stock | 11255 | $0.00 | 121,063.0000 | 0 | 10.25% | 0.00% |
| April 2, 2024 | Hughes Douglas J. | Director | A | Stock Option (right to buy) | 4690 | $0.00 | 4,690.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | Salzmann Peter | Chief Executive Officer | A | Common Stock | 160534 | $0.00 | 1,091,765.0000 | 0 | 17.24% | 0.00% |
| April 2, 2024 | Fromkin Andrew J. | Director | A | Stock Option (right to buy) | 4690 | $0.00 | 4,690.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | Fromkin Andrew J. | Director | A | Common Stock | 11255 | $0.00 | 99,913.0000 | 0 | 12.69% | 0.00% |
| April 2, 2024 | Barnett Eva Renee | Chief Financial Officer | A | Stock Option (right to buy) | 68723 | $0.00 | 68,723.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | Barnett Eva Renee | Chief Financial Officer | A | Common Stock | 54978 | $0.00 | 375,398.0000 | 0 | 17.16% | 0.00% |
| April 2, 2024 | Butchko Julia G. | Chief Development Officer | A | Stock Option (right to buy) | 68723 | $0.00 | 68,723.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | Butchko Julia G. | Chief Development Officer | A | Common Stock | 54978 | $0.00 | 462,795.0000 | 0 | 13.48% | 0.00% |
| April 2, 2024 | Geffner Michael | Chief Medical Officer | A | Stock Option (right to buy) | 68723 | $0.00 | 68,723.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | Geffner Michael | Chief Medical Officer | A | Common Stock | 54978 | $0.00 | 144,877.0000 | 0 | 61.16% | 0.00% |
| April 2, 2024 | Macias William L. | Chief Medical Officer | A | Stock Option (right to buy) | 68723 | $0.00 | 68,723.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | Macias William L. | Chief Medical Officer | A | Common Stock | 54978 | $0.00 | 385,930.0000 | 0 | 16.61% | 0.00% |
| Feb. 22, 2024 | Butchko Julia G. | Chief Development Officer | S | Common Stock | 2146 | $36.15 | 407,817.0000 | 0 | 0.52% | 0.00% |
| Feb. 22, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 13454 | $36.15 | 931,231.0000 | 0 | 1.42% | 0.00% |
| Feb. 22, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2930 | $36.15 | 320,420.0000 | 0 | 0.91% | 0.00% |
| Feb. 22, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 2221 | $36.15 | 330,952.0000 | 0 | 0.67% | 0.00% |
| Feb. 22, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 2134 | $36.15 | 301,968.0000 | 0 | 0.70% | 0.00% |
| Jan. 26, 2024 | Geffner Michael | Chief Medical Officer | S | Common Stock | 153 | $38.45 | 89,899.0000 | 0 | 0.17% | 0.00% |
| Jan. 26, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 2981 | $37.91 | 304,148.0000 | 0 | 0.97% | 0.00% |
| Jan. 26, 2024 | Levine Mark S. | Chief Legal Officer | S | Common Stock | 46 | $38.45 | 304,102.0000 | 0 | 0.02% | 0.00% |
| Jan. 26, 2024 | Geffner Michael | Chief Medical Officer | S | Common Stock | 9948 | $37.91 | 90,052.0000 | 0 | 9.95% | 0.00% |
| Jan. 18, 2024 | Macias William L. | Chief Medical Officer | S | Common Stock | 424 | $41.03 | 333,173.0000 | 0 | 0.13% | 0.00% |
| Jan. 11, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 2681 | $41.64 | 324,184.0000 | 0 | 0.82% | 0.00% |
| Jan. 11, 2024 | Barnett Eva Renee | Chief Financial Officer | S | Common Stock | 834 | $42.43 | 323,350.0000 | 0 | 0.26% | 0.00% |
| Jan. 5, 2024 | Butchko Julia G. | Chief Development Officer | S | Common Stock | 1297 | $38.59 | 409,963.0000 | 0 | 0.32% | 0.00% |
| Jan. 5, 2024 | Salzmann Peter | Chief Executive Officer | S | Common Stock | 3824 | $38.59 | 944,685.0000 | 0 | 0.40% | 0.00% |